Mitteilungen der DGN
Nervenarzt. 2024 Apr;95(4):388-402. doi: 10.1007/s00115-024-01648-y.NO ABSTRACTPMID:38607402 | DOI:10.1007/s00115-024-01648-y (Source: Der Nervenarzt)
Source: Der Nervenarzt - April 12, 2024 Category: Neurology Source Type: research
Mitteilungen der Deutschen Schlaganfall-Gesellschaft (DSG)
Nervenarzt. 2024 Apr;95(4):403-404. doi: 10.1007/s00115-024-01653-1.NO ABSTRACTPMID:38607403 | DOI:10.1007/s00115-024-01653-1 (Source: Der Nervenarzt)
Source: Der Nervenarzt - April 12, 2024 Category: Neurology Source Type: research
Clinical management of treatment-resistant depression
Nervenarzt. 2024 Apr 3. doi: 10.1007/s00115-024-01647-z. Online ahead of print.ABSTRACTTreatment-resistant depression (TRD) is a complex disorder. Although no standardized definition has been established to date, there are promising and well-established treatment options for the condition. Looking at the current pharmacological and neuromodulatory strategies, there is an urgent need for fast-acting and well-tolerated treatment options. The search for new mechanisms of action goes beyond the monoamine hypothesis. For example, esketamine is already an established treatment method that is fast-acting and well tolerated, while...
Source: Der Nervenarzt - April 3, 2024 Category: Neurology Authors: Bernhard T Baune Sarah E Fromme Maximilian Kiebs Ren é Hurlemann Source Type: research
Clinical management of treatment-resistant depression
Nervenarzt. 2024 Apr 3. doi: 10.1007/s00115-024-01647-z. Online ahead of print.ABSTRACTTreatment-resistant depression (TRD) is a complex disorder. Although no standardized definition has been established to date, there are promising and well-established treatment options for the condition. Looking at the current pharmacological and neuromodulatory strategies, there is an urgent need for fast-acting and well-tolerated treatment options. The search for new mechanisms of action goes beyond the monoamine hypothesis. For example, esketamine is already an established treatment method that is fast-acting and well tolerated, while...
Source: Der Nervenarzt - April 3, 2024 Category: Neurology Authors: Bernhard T Baune Sarah E Fromme Maximilian Kiebs Ren é Hurlemann Source Type: research
Clinical management of treatment-resistant depression
Nervenarzt. 2024 Apr 3. doi: 10.1007/s00115-024-01647-z. Online ahead of print.ABSTRACTTreatment-resistant depression (TRD) is a complex disorder. Although no standardized definition has been established to date, there are promising and well-established treatment options for the condition. Looking at the current pharmacological and neuromodulatory strategies, there is an urgent need for fast-acting and well-tolerated treatment options. The search for new mechanisms of action goes beyond the monoamine hypothesis. For example, esketamine is already an established treatment method that is fast-acting and well tolerated, while...
Source: Der Nervenarzt - April 3, 2024 Category: Neurology Authors: Bernhard T Baune Sarah E Fromme Maximilian Kiebs Ren é Hurlemann Source Type: research
Clinical management of treatment-resistant depression
Nervenarzt. 2024 Apr 3. doi: 10.1007/s00115-024-01647-z. Online ahead of print.ABSTRACTTreatment-resistant depression (TRD) is a complex disorder. Although no standardized definition has been established to date, there are promising and well-established treatment options for the condition. Looking at the current pharmacological and neuromodulatory strategies, there is an urgent need for fast-acting and well-tolerated treatment options. The search for new mechanisms of action goes beyond the monoamine hypothesis. For example, esketamine is already an established treatment method that is fast-acting and well tolerated, while...
Source: Der Nervenarzt - April 3, 2024 Category: Neurology Authors: Bernhard T Baune Sarah E Fromme Maximilian Kiebs Ren é Hurlemann Source Type: research
Clinical management of treatment-resistant depression
Nervenarzt. 2024 Apr 3. doi: 10.1007/s00115-024-01647-z. Online ahead of print.ABSTRACTTreatment-resistant depression (TRD) is a complex disorder. Although no standardized definition has been established to date, there are promising and well-established treatment options for the condition. Looking at the current pharmacological and neuromodulatory strategies, there is an urgent need for fast-acting and well-tolerated treatment options. The search for new mechanisms of action goes beyond the monoamine hypothesis. For example, esketamine is already an established treatment method that is fast-acting and well tolerated, while...
Source: Der Nervenarzt - April 3, 2024 Category: Neurology Authors: Bernhard T Baune Sarah E Fromme Maximilian Kiebs Ren é Hurlemann Source Type: research
Clinical management of treatment-resistant depression
Nervenarzt. 2024 Apr 3. doi: 10.1007/s00115-024-01647-z. Online ahead of print.ABSTRACTTreatment-resistant depression (TRD) is a complex disorder. Although no standardized definition has been established to date, there are promising and well-established treatment options for the condition. Looking at the current pharmacological and neuromodulatory strategies, there is an urgent need for fast-acting and well-tolerated treatment options. The search for new mechanisms of action goes beyond the monoamine hypothesis. For example, esketamine is already an established treatment method that is fast-acting and well tolerated, while...
Source: Der Nervenarzt - April 3, 2024 Category: Neurology Authors: Bernhard T Baune Sarah E Fromme Maximilian Kiebs Ren é Hurlemann Source Type: research
Clinical characteristics and diagnostics of human spongiform encephalopathies: an update
Nervenarzt. 2024 Mar 19. doi: 10.1007/s00115-024-01644-2. Online ahead of print.ABSTRACTHuman spongiform encephalopathies are rare transmissible neurodegenerative diseases of the brain and the nervous system that are caused by misfolding of the physiological prion protein into a pathological form and its deposition in the central nervous system (CNS). Prion diseases include Creutzfeldt-Jakob disease (CJD, sporadic or familial), Gerstmann-Straussler-Scheinker syndrome (GSS) and fatal familial insomnia (FFI). Prion diseases can be differentiated into three etiological categories: spontaneous (sporadic CJD), inherited (famili...
Source: Der Nervenarzt - March 20, 2024 Category: Neurology Authors: Peter Hermann Stefan Goebel Inga Zerr Source Type: research
Patient and public involvement at the German Center for Mental Health: achievements and challenges
CONCLUSION: A PPI strategy at the DZPG has been successfully developed and is currently being implemented by the cross-center infrastructure Center for PPI.PMID:38506976 | DOI:10.1007/s00115-024-01630-8 (Source: Der Nervenarzt)
Source: Der Nervenarzt - March 20, 2024 Category: Neurology Authors: Silke Lipinski Ulrike S ünkel Christina Totzeck Thomas Dresler Irina Baskow Myriam Bea R üdiger Hannig Isabel Dziobek Source Type: research
Clinical characteristics and diagnostics of human spongiform encephalopathies: an update
Nervenarzt. 2024 Mar 19. doi: 10.1007/s00115-024-01644-2. Online ahead of print.ABSTRACTHuman spongiform encephalopathies are rare transmissible neurodegenerative diseases of the brain and the nervous system that are caused by misfolding of the physiological prion protein into a pathological form and its deposition in the central nervous system (CNS). Prion diseases include Creutzfeldt-Jakob disease (CJD, sporadic or familial), Gerstmann-Straussler-Scheinker syndrome (GSS) and fatal familial insomnia (FFI). Prion diseases can be differentiated into three etiological categories: spontaneous (sporadic CJD), inherited (famili...
Source: Der Nervenarzt - March 20, 2024 Category: Neurology Authors: Peter Hermann Stefan Goebel Inga Zerr Source Type: research
Patient and public involvement at the German Center for Mental Health: achievements and challenges
CONCLUSION: A PPI strategy at the DZPG has been successfully developed and is currently being implemented by the cross-center infrastructure Center for PPI.PMID:38506976 | DOI:10.1007/s00115-024-01630-8 (Source: Der Nervenarzt)
Source: Der Nervenarzt - March 20, 2024 Category: Neurology Authors: Silke Lipinski Ulrike S ünkel Christina Totzeck Thomas Dresler Irina Baskow Myriam Bea R üdiger Hannig Isabel Dziobek Source Type: research
Clinical characteristics and diagnostics of human spongiform encephalopathies: an update
Nervenarzt. 2024 Mar 19. doi: 10.1007/s00115-024-01644-2. Online ahead of print.ABSTRACTHuman spongiform encephalopathies are rare transmissible neurodegenerative diseases of the brain and the nervous system that are caused by misfolding of the physiological prion protein into a pathological form and its deposition in the central nervous system (CNS). Prion diseases include Creutzfeldt-Jakob disease (CJD, sporadic or familial), Gerstmann-Straussler-Scheinker syndrome (GSS) and fatal familial insomnia (FFI). Prion diseases can be differentiated into three etiological categories: spontaneous (sporadic CJD), inherited (famili...
Source: Der Nervenarzt - March 20, 2024 Category: Neurology Authors: Peter Hermann Stefan Goebel Inga Zerr Source Type: research
Patient and public involvement at the German Center for Mental Health: achievements and challenges
CONCLUSION: A PPI strategy at the DZPG has been successfully developed and is currently being implemented by the cross-center infrastructure Center for PPI.PMID:38506976 | DOI:10.1007/s00115-024-01630-8 (Source: Der Nervenarzt)
Source: Der Nervenarzt - March 20, 2024 Category: Neurology Authors: Silke Lipinski Ulrike S ünkel Christina Totzeck Thomas Dresler Irina Baskow Myriam Bea R üdiger Hannig Isabel Dziobek Source Type: research
Clinical characteristics and diagnostics of human spongiform encephalopathies: an update
Nervenarzt. 2024 Mar 19. doi: 10.1007/s00115-024-01644-2. Online ahead of print.ABSTRACTHuman spongiform encephalopathies are rare transmissible neurodegenerative diseases of the brain and the nervous system that are caused by misfolding of the physiological prion protein into a pathological form and its deposition in the central nervous system (CNS). Prion diseases include Creutzfeldt-Jakob disease (CJD, sporadic or familial), Gerstmann-Straussler-Scheinker syndrome (GSS) and fatal familial insomnia (FFI). Prion diseases can be differentiated into three etiological categories: spontaneous (sporadic CJD), inherited (famili...
Source: Der Nervenarzt - March 20, 2024 Category: Neurology Authors: Peter Hermann Stefan Goebel Inga Zerr Source Type: research
